West Chester, PA, United States of America

Eugene Cruz Amparo


Average Co-Inventor Count = 6.9

ph-index = 5

Forward Citations = 127(Granted Patents)


Location History:

  • West Chester, PA (US) (1995 - 2000)
  • Downington, PA (US) (2001 - 2003)

Company Filing History:


Years Active: 1995-2003

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Eugene Cruz Amparo

Introduction

Eugene Cruz Amparo is a notable inventor based in West Chester, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for factor Xa. With a total of 6 patents to his name, Amparo's work has had a considerable impact on medical research and drug development.

Latest Patents

Among his latest patents are formulations involving benzimidazolinones, benzoxazolinones, benzopiperazinones, and indanones. These compounds are recognized for their potential as inhibitors of factor Xa, which plays a crucial role in the coagulation cascade. The present application describes inhibitors of factor Xa of formula I, showcasing the innovative nature of his research.

Career Highlights

Eugene Cruz Amparo has worked with prominent companies in the pharmaceutical industry, including the DuPont Merck Pharmaceutical Company and DuPont Pharmaceuticals Company. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field.

Collaborations

Throughout his career, Amparo has collaborated with esteemed colleagues such as Gregory James Pacofsky and William Henry Miller. These partnerships have further enhanced the quality and scope of his research endeavors.

Conclusion

Eugene Cruz Amparo's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…